Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Queensland Health
Federal Trade Commission
Baxter
Harvard Business School
Mallinckrodt
Covington
Cipla
Citi

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016998

« Back to Dashboard

NDA 016998 describes UTICORT, which is a drug marketed by Parke Davis and is included in four NDAs. Additional details are available on the UTICORT profile page.

The generic ingredient in UTICORT is betamethasone benzoate. There are sixty-six drug master file entries for this compound. Additional details are available on the betamethasone benzoate profile page.
Summary for 016998
Tradename:UTICORT
Applicant:Parke Davis
Ingredient:betamethasone benzoate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength0.025%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Covington
Harvard Business School
Johnson and Johnson
UBS
QuintilesIMS
Teva
Argus Health
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot